1
Fulvio Foschini, Marcello Stagni, Giulio Luciani, Pierre Roy: Cross-linking composition delivered by iontophoresis, useful for the treatment of keratoconus. SOOFT ITALIA, Young & Thompson, September 13, 2016: US09439908

An improved formulation of an ophthalmic composition contains riboflavin, as cross-linking agent of corneal collagen, administered by corneal iontophoresis, able to guarantee an increased capacity of permeation of riboflavin of the corneal stroma and therefore greater therapeutic efficacy in the tre ...


2
FOSCHINI Fulvio, STAGNI Marcello, LUCIANI Giulio: [fr] COMPOSITION DE RÉTICULATION AMÉLIORÉE ADMINISTRÉE PAR IONOPHORÈSE, UTILE POUR LE TRAITEMENT DU KÉRATOCÔNE, [en] IMPROVED CROSS-LINKING COMPOSITION DELIVERED BY IONTOPHORESIS, USEFUL FOR THE TREATMENT OF KERATOCONUS. SOOFT ITALIA, SARPI Maurizio, May 2, 2013: WO/2013/061350

[en] The present invention relates to an improved formulation of an ophthalmic composition containing riboflavin, as cross-linking agent of corneal collagen, administered by corneal iontophoresis, able to guarantee an increased capacity of permeation of riboflavin of the corneal stroma and therefore ...


3
CROSS-LINKING COMPOSITION DELIVERED BY IONTOPHORESIS, USEFUL FOR THE TREATMENT OF KERATOCONUS. October 9, 2014: US20140303173-A1

An improved formulation of an ophthalmic composition contains riboflavin, as cross-linking agent of corneal collagen, administered by corneal iontophoresis, able to guarantee an increased capacity of permeation of riboflavin of the corneal stroma and therefore greater therapeutic efficacy in the tre ...


4
[ZH] 用于圆锥形角膜治疗的由离子透入法递送的改良的交联组合物, [EN] Improved cross-linking composition delivered by iontophoresis, useful for the treatment of keratoconus. September 3, 2014: CN107368570

[EN] The present invention relates to an improved formulation of an ophthalmic composition containing riboflavin, as cross-linking agent of corneal collagen, administered by corneal iontophoresis, able to guarantee an increased capacity of permeation of riboflavin of the corneal stroma and therefore ...



Click the thumbnails below to visualize the patent trend.